Altogether, these studies underline the link between EVs, BRAFV600E and BRAF-inhibitor resistance in melanoma while stressing the need for additional functional and in vivo studies as well as an extension to BRAFV600E-dependent TC. This evidence concerns the gene BRAF and melanoma.